Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lizhou Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1137-1635; OpenAlex author ID A5051776596. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 8

  1. UTMD inhibits pancreatic cancer growth and metastasis by inducing macrophage polarization and vessel normalization. Co-author DOI 10.1016/j.biopha.2023.114322↗
  2. The Long-Term Fate of the Sonoporated Pancreatic Cancer Cells is Uncorrelated With the Degree of Model Molecular Loading. Co-author DOI 10.1016/j.ultrasmedbio.2019.10.026↗
  3. Biodegradable, pH-Sensitive Hollow Mesoporous Organosilica Nanoparticle (HMON) with Controlled Release of Pirfenidone and Ultrasound-Target-Microbubble-Destruc… Co-author DOI 10.7150/thno.36135↗
  4. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy. Co-author DOI 10.7150/thno.22834↗
  5. Role of microenvironmental periostin in pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.11533↗
  6. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5321-6↗
  7. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Co-author DOI 10.18632/oncotarget.9512↗
  8. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic … Co-author DOI 10.7150/thno.15164↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lianfang Du · 5 shared papers, 2016–2023 · strength 0.59
  2. Peng Qin · 5 shared papers, 2016–2020 · strength 0.38
  3. Feng Gao · 5 shared papers, 2016–2019 · strength 0.34
  4. Fan Li · 4 shared papers, 2016–2018 · strength 0.25
  5. Lingxi Xing · 4 shared papers, 2016–2017 · strength 0.23
  6. Lianfang Du · 3 shared papers, 2016–2017 · strength 0.17
  7. Jiajie Zhang · 3 shared papers, 2016–2017 · strength 0.17
  8. Xiangyang Shi · 1 shared paper, 2018 · strength 0.08
  9. Dan Li · 1 shared paper, 2018 · strength 0.08
  10. Yang Liu · 1 shared paper, 2017 · strength 0.06
  11. Yang Liu · 1 shared paper, 2016 · strength 0.05
  12. Liu Yang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.